With drug resistance towards malarial treatments growing, the medical community is increasingly looking towards vaccines to halt the spread of this mosquito-borne disease. — AFP
After decades of work, the World Health Organization (WHO) endorsed the first-ever malaria vaccine last year – a historic milestone that promised to drive back a disease that kills a child every minute.
In reality, efforts are falling well short of that, with a lack of funding and commercial potential thwarting GSK Plc’s capacity to produce as many doses of its shot as needed, according to interviews with about a dozen WHO officials, GSK staff, scientists and non-profit groups.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
